Yuebing Li

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

Medicine, Surgery, Clinical Trials +1

Spectrum and Potential Pathogenesis of Reversible Posterior Leukoencephalopathy Syndrome

Yuebing Li, Devang M. Gor, Debra Walicki et al. · Journal of Stroke and Cerebrovascular Diseases · 2011 · 88 citations

Potential Pathogenesis, Neurological Disorder, Neurology +2

Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center

Yuebing Li, Adham Jammoul, Karin Mente et al. · Muscle & Nerve · 2014 · 53 citations

Myasthenia gravis exacerbation associated with pembrolizumab

Julia Zhu, Yuebing Li · Muscle & Nerve · 2016 · 52 citations

Disease Mechanism, Autoimmune Disease, Myasthenia Gravis Exacerbation +4